Treatments

Treatments

An Expert’s Insight to Lung Cancer Treatment Developments

D. Ross Camidge, MD, PhD, Laura Levaas

Treatments

Why Should Lung Cancer Patients Consider a Clinical Trial?

Jessica Wittebort, Lecia Sequist, MD, MPH - DF/HCC, Janet Freeman-Daily, Andrew Schorr

Treatments

Will CAR T-Cell Therapy Benefit Lung Cancer Patients?

Jhanelle Gray, MD, Andrew Schorr

Treatments

What Role Does Radiation Play in Lung Cancer Care?

Stephen A. Rosenberg, MD, MS, Jhanelle Gray, MD, Andrew Schorr

Treatments

Immunotherapy Update for Lung Cancer: What Kind of Patients Will Benefit?

Jeffrey Crawford, MD, Edward S. Kim, MD, Andrew Schorr

Treatments

Are Side Effects More Severe for Lung Cancer Patients With Multiple Mutations?

Christine Lovly, MD, PhD

Treatments

Are Targeted Therapy Side Effect Profiles in Lung Cancer Improving?

Christine Lovly, MD, PhD, Andrew Schorr

Treatments

Patient Question: What Is the Next Step on My Lung Cancer Treatment Journey?

Christine Lovly, MD, PhD, Andrew Schorr

Treatments

NSCLC vs. SCLC: Why Are They Treated Differently?

Laura Chow, MD, Andrew Schorr

Treatments

When Is Immunotherapy An Option For Lung Cancer Patients?

Frank Griesinger, Dr.

Treatments

Immunotherapy: An Option for All Lung Cancer Patients?

Charles Swanton, Professor

Treatments

What Treatment Options Are Available for Lung Cancer Patients With No Driver Mutations?

Don Stranathan, Bruce E. Johnson, MD, Alex Spira, MD, PhD, FACP, Andrew Schorr

Knowledge is power.

Subscribe to e-newsletter(s) to receive emerging research and community updates right to your inbox.

Subscribe